My EDIT entry idea on March 4, 2019 is up about 28% and is soon likely to re-trace about 1/2 of the recent ramp from $20. While it charts out to about $40 next year, near term (8-10 weeks), it could come back in to the $24 to $25 range. Consider taking partial/full profits.
EDIT could provide another entry for the run to $40 near the end of February which would be timed well with the broader market expansion.
Editas Medicine Inc (EDIT) daily
